SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stressgen (VSE: SSB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: brent groh who wrote (3)8/16/1996 4:32:00 PM
From: Andy Patton   of 236
 
Hi:

Part of the reason for Stressgen's climb from $3.00 to $4+ is that AGF Growth Equity recently bought a position in Stressgen. Also, I noticed in yesterday's trading that someone was busy buying up about 500,000 shares--quite a sizeable position, which cost in that day's trading about $1.75 M. Don't have any idea who, but this trade was crossed at Nesbitt Burns.

-Andy Patton
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News